| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.3 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |